Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 54 entries
Sorted by: Best Match Show Resources per page
American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report.

Annals of the American Thoracic Society

Bender BG, Krishnan JA, Chambers DA, Cloutier MM, Riekert KA, Rand CS, Schatz M, Thomson CC, Wilson SR, Apter A, Carson SS, George M, Gerald JK, Gerald L, Goss CH, Okelo SO, Mularski RA, Nguyen HQ, Patel MR, Szefler SJ, Weiss CH, Wilson KC, Freemer M.
PMID: 26653201
Ann Am Thorac Soc. 2015 Dec;12(12):S213-21. doi: 10.1513/AnnalsATS.201506-367OT.

To advance implementation research (IR) in respiratory, sleep, and critical care medicine, the American Thoracic Society and the Division of Lung Diseases from the NHLBI cosponsored an Implementation Research Workshop on May 17, 2014. The goals of IR are...

Cite
Bender BG, Krishnan JA, Chambers DA, et al. American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report. Ann Am Thorac Soc. 2015;12(12):S213-21doi: 10.1513/AnnalsATS.201506-367OT.
Bender, B. G., Krishnan, J. A., Chambers, D. A., Cloutier, M. M., Riekert, K. A., Rand, C. S., Schatz, M., Thomson, C. C., Wilson, S. R., Apter, A., Carson, S. S., George, M., Gerald, J. K., Gerald, L., Goss, C. H., Okelo, S. O., Mularski, R. A., Nguyen, H. Q., Patel, M. R., Szefler, S. J., Weiss, C. H., Wilson, K. C., & Freemer, M. (2015). American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report. Annals of the American Thoracic Society, 12(12), S213-21. https://doi.org/10.1513/AnnalsATS.201506-367OT
Bender, Bruce G, et al. "American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report." Annals of the American Thoracic Society vol. 12,12 (2015): S213-21. doi: https://doi.org/10.1513/AnnalsATS.201506-367OT
Bender BG, Krishnan JA, Chambers DA, Cloutier MM, Riekert KA, Rand CS, Schatz M, Thomson CC, Wilson SR, Apter A, Carson SS, George M, Gerald JK, Gerald L, Goss CH, Okelo SO, Mularski RA, Nguyen HQ, Patel MR, Szefler SJ, Weiss CH, Wilson KC, Freemer M. American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report. Ann Am Thorac Soc. 2015 Dec;12(12):S213-21. doi: 10.1513/AnnalsATS.201506-367OT. PMID: 26653201; PMCID: PMC5467083.
Copy Download .nbib Format: NLM
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.

Harm reduction journal

Todd CS, Nasir A, Stanekzai MR, Fiekert K, Rasuli MZ, Vlahov D, Strathdee SA.
PMID: 21867518
Harm Reduct J. 2011 Aug 25;8:22. doi: 10.1186/1477-7517-8-22.

BACKGROUND: A nascent HIV epidemic and high prevalence of risky drug practices were detected among injecting drug users (IDUs) in Kabul, Afghanistan from 2005-2006. We assessed prevalence of HIV, hepatitis C virus (HCV), hepatitis B surface antigen (HBsAg), syphilis,...

Cite
Todd CS, Nasir A, Stanekzai MR, et al. Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment. Harm Reduct J. 2011;8:22doi: 10.1186/1477-7517-8-22.
Todd, C. S., Nasir, A., Stanekzai, M. R., Fiekert, K., Rasuli, M. Z., Vlahov, D., & Strathdee, S. A. (2011). Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment. Harm reduction journal, 822. https://doi.org/10.1186/1477-7517-8-22
Todd, Catherine S, et al. "Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment." Harm reduction journal vol. 8 (2011): 22. doi: https://doi.org/10.1186/1477-7517-8-22
Todd CS, Nasir A, Stanekzai MR, Fiekert K, Rasuli MZ, Vlahov D, Strathdee SA. Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment. Harm Reduct J. 2011 Aug 25;8:22. doi: 10.1186/1477-7517-8-22. PMID: 21867518; PMCID: PMC3180253.
Copy Download .nbib Format: NLM
Nonclassical oxygen atom transfer reactions of oxomolybdenum(VI) bis(catecholate).

Chemical communications (Cambridge, England)

Marshall-Roth T, Liebscher SC, Rickert K, Seewald NJ, Oliver AG, Brown SN.
PMID: 22785616
Chem Commun (Camb). 2012 Aug 14;48(63):7826-8. doi: 10.1039/c2cc33523a. Epub 2012 Jul 02.

Mechanistic studies indicate that the oxomolybdenum(vi) bis(3,5-di-tert-butylcatecholate) fragment deoxygenates pyridine-N-oxides in a reaction where the oxygen is delivered to molybdenum but the electrons for substrate reduction are drawn from the bound catecholate ligands, forming 3,5-di-tert-butyl-1,2-benzoquinone.

Cite
Marshall-Roth T, Liebscher SC, Rickert K, et al. Nonclassical oxygen atom transfer reactions of oxomolybdenum(VI) bis(catecholate). Chem Commun (Camb). 2012;48(63):7826-8doi: 10.1039/c2cc33523a.
Marshall-Roth, T., Liebscher, S. C., Rickert, K., Seewald, N. J., Oliver, A. G., & Brown, S. N. (2012). Nonclassical oxygen atom transfer reactions of oxomolybdenum(VI) bis(catecholate). Chemical communications (Cambridge, England), 48(63), 7826-8. https://doi.org/10.1039/c2cc33523a
Marshall-Roth, Travis, et al. "Nonclassical oxygen atom transfer reactions of oxomolybdenum(VI) bis(catecholate)." Chemical communications (Cambridge, England) vol. 48,63 (2012): 7826-8. doi: https://doi.org/10.1039/c2cc33523a
Marshall-Roth T, Liebscher SC, Rickert K, Seewald NJ, Oliver AG, Brown SN. Nonclassical oxygen atom transfer reactions of oxomolybdenum(VI) bis(catecholate). Chem Commun (Camb). 2012 Aug 14;48(63):7826-8. doi: 10.1039/c2cc33523a. Epub 2012 Jul 02. PMID: 22785616.
Copy Download .nbib Format: NLM
Non-natural phenolic amino acids Synthesis and application in peptide chemistry.

Amino acids

Hutinec A, Ziogas A, Rieker A.
PMID: 24178721
Amino Acids. 1996 Sep;11(3):345-66. doi: 10.1007/BF00807941.

Several non-natural phenolic amino acids have been synthesized.t-Butylated tyrosine and thyroxine derivatives, on one-electron oxidation, give persistent radicals which can be used as positional and/or spin labels for amino acids. Two-electron oxidation ofN-protected tyrosines leads to spirolactones, useful active...

Cite
Hutinec A, Ziogas A, Rieker A. Non-natural phenolic amino acids Synthesis and application in peptide chemistry. Amino Acids. 1996;11(3):345-66doi: 10.1007/BF00807941.
Hutinec, A., Ziogas, A., & Rieker, A. (1996). Non-natural phenolic amino acids Synthesis and application in peptide chemistry. Amino acids, 11(3), 345-66. https://doi.org/10.1007/BF00807941
Hutinec, A, et al. "Non-natural phenolic amino acids Synthesis and application in peptide chemistry." Amino acids vol. 11,3 (1996): 345-66. doi: https://doi.org/10.1007/BF00807941
Hutinec A, Ziogas A, Rieker A. Non-natural phenolic amino acids Synthesis and application in peptide chemistry. Amino Acids. 1996 Sep;11(3):345-66. doi: 10.1007/BF00807941. PMID: 24178721.
Copy Download .nbib Format: NLM
Chemical Unit Cosubstitution and Tuning of Photoluminescence in the Ca2(Al(1-x)Mg(x))(Al(1-x)Si(1+x))O7:Eu(2+) Phosphor.

Journal of the American Chemical Society

Xia Z, Ma C, Molokeev MS, Liu Q, Rickert K, Poeppelmeier KR.
PMID: 26389578
J Am Chem Soc. 2015 Oct 07;137(39):12494-7. doi: 10.1021/jacs.5b08315. Epub 2015 Sep 25.

The union of structural and spectroscopic modeling can accelerate the discovery and improvement of phosphor materials if guided by an appropriate principle. Herein, we describe the concept of "chemical unit cosubstitution" as one such potential design scheme. We corroborate...

Cite
Xia Z, Ma C, Molokeev MS, et al. Chemical Unit Cosubstitution and Tuning of Photoluminescence in the Ca2(Al(1-x)Mg(x))(Al(1-x)Si(1+x))O7:Eu(2+) Phosphor. J Am Chem Soc. 2015;137(39):12494-7doi: 10.1021/jacs.5b08315.
Xia, Z., Ma, C., Molokeev, M. S., Liu, Q., Rickert, K., & Poeppelmeier, K. R. (2015). Chemical Unit Cosubstitution and Tuning of Photoluminescence in the Ca2(Al(1-x)Mg(x))(Al(1-x)Si(1+x))O7:Eu(2+) Phosphor. Journal of the American Chemical Society, 137(39), 12494-7. https://doi.org/10.1021/jacs.5b08315
Xia, Zhiguo, et al. "Chemical Unit Cosubstitution and Tuning of Photoluminescence in the Ca2(Al(1-x)Mg(x))(Al(1-x)Si(1+x))O7:Eu(2+) Phosphor." Journal of the American Chemical Society vol. 137,39 (2015): 12494-7. doi: https://doi.org/10.1021/jacs.5b08315
Xia Z, Ma C, Molokeev MS, Liu Q, Rickert K, Poeppelmeier KR. Chemical Unit Cosubstitution and Tuning of Photoluminescence in the Ca2(Al(1-x)Mg(x))(Al(1-x)Si(1+x))O7:Eu(2+) Phosphor. J Am Chem Soc. 2015 Oct 07;137(39):12494-7. doi: 10.1021/jacs.5b08315. Epub 2015 Sep 25. PMID: 26389578.
Copy Download .nbib Format: NLM
Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Montemayor K, Psoter KJ, Lechtzin N, Carson SW, Merlo CA, Dezube RH, Riekert KA, Allgood S, Toporek A, Jennings MT, West NE.
PMID: 34090802
J Cyst Fibros. 2021 Nov;20(6):920-925. doi: 10.1016/j.jcf.2021.05.012. Epub 2021 Jun 03.

BACKGROUND: Females with cystic fibrosis (CF) have been shown to have worse pulmonary exacerbation (PEx) related outcomes compared to males. However, it is unknown if sex differences in treatment patterns are contributing to these outcomes. Thus, we sought to...

Cite
Montemayor K, Psoter KJ, Lechtzin N, et al. Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations. J Cyst Fibros. 2021;20(6):920-925doi: 10.1016/j.jcf.2021.05.012.
Montemayor, K., Psoter, K. J., Lechtzin, N., Carson, S. W., Merlo, C. A., Dezube, R. H., Riekert, K. A., Allgood, S., Toporek, A., Jennings, M. T., & West, N. E. (2021). Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 20(6), 920-925. https://doi.org/10.1016/j.jcf.2021.05.012
Montemayor, Kristina, et al. "Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations." Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 20,6 (2021): 920-925. doi: https://doi.org/10.1016/j.jcf.2021.05.012
Montemayor K, Psoter KJ, Lechtzin N, Carson SW, Merlo CA, Dezube RH, Riekert KA, Allgood S, Toporek A, Jennings MT, West NE. Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations. J Cyst Fibros. 2021 Nov;20(6):920-925. doi: 10.1016/j.jcf.2021.05.012. Epub 2021 Jun 03. PMID: 34090802; PMCID: PMC8636543.
Copy Download .nbib Format: NLM
Thermal Energy Transport in Oxide Nuclear Fuel.

Chemical reviews

Hurley DH, El-Azab A, Bryan MS, Cooper MWD, Dennett CA, Gofryk K, He L, Khafizov M, Lander GH, Manley ME, Mann JM, Marianetti CA, Rickert K, Selim FA, Tonks MR, Wharry JP.
PMID: 34919381
Chem Rev. 2021 Dec 17; doi: 10.1021/acs.chemrev.1c00262. Epub 2021 Dec 17.

To efficiently capture the energy of the nuclear bond, advanced nuclear reactor concepts seek solid fuels that must withstand unprecedented temperature and radiation extremes. In these advanced fuels, thermal energy transport under irradiation is directly related to reactor performance...

Cite
Hurley DH, El-Azab A, Bryan MS, et al. Thermal Energy Transport in Oxide Nuclear Fuel. Chem Rev. 2021;doi: 10.1021/acs.chemrev.1c00262.
Hurley, D. H., El-Azab, A., Bryan, M. S., Cooper, M. W. D., Dennett, C. A., Gofryk, K., He, L., Khafizov, M., Lander, G. H., Manley, M. E., Mann, J. M., Marianetti, C. A., Rickert, K., Selim, F. A., Tonks, M. R., & Wharry, J. P. (2021). Thermal Energy Transport in Oxide Nuclear Fuel. Chemical reviews, . https://doi.org/10.1021/acs.chemrev.1c00262
Hurley, David H, et al. "Thermal Energy Transport in Oxide Nuclear Fuel." Chemical reviews vol. (2021). doi: https://doi.org/10.1021/acs.chemrev.1c00262
Hurley DH, El-Azab A, Bryan MS, Cooper MWD, Dennett CA, Gofryk K, He L, Khafizov M, Lander GH, Manley ME, Mann JM, Marianetti CA, Rickert K, Selim FA, Tonks MR, Wharry JP. Thermal Energy Transport in Oxide Nuclear Fuel. Chem Rev. 2021 Dec 17; doi: 10.1021/acs.chemrev.1c00262. Epub 2021 Dec 17. PMID: 34919381.
Copy Download .nbib Format: NLM
Prospective Study of Use of Edmonton Symptom Assessment Scale Versus Routine Symptom Management During Weekly Radiation Treatment Visits.

JCO oncology practice

Goyal UD, Riegert K, Davuluri R, Ong S, Yi SK, Dougherty ST, Hsu CC.
PMID: 32384015
JCO Oncol Pract. 2020 Sep;16(9):e1029-e1035. doi: 10.1200/JOP.19.00465. Epub 2020 May 08.

PURPOSE: During radiotherapy (RT), patient symptoms are evaluated and managed weekly during physician on-treatment visits (OTVs). The Edmonton Symptom Assessment Scale (ESAS) is a 9-symptom validated self-assessment tool for reporting common symptoms in patients with cancer. We hypothesized that...

Cite
Goyal UD, Riegert K, Davuluri R, et al. Prospective Study of Use of Edmonton Symptom Assessment Scale Versus Routine Symptom Management During Weekly Radiation Treatment Visits. JCO Oncol Pract. 2020;16(9):e1029-e1035doi: 10.1200/JOP.19.00465.
Goyal, U. D., Riegert, K., Davuluri, R., Ong, S., Yi, S. K., Dougherty, S. T., & Hsu, C. C. (2020). Prospective Study of Use of Edmonton Symptom Assessment Scale Versus Routine Symptom Management During Weekly Radiation Treatment Visits. JCO oncology practice, 16(9), e1029-e1035. https://doi.org/10.1200/JOP.19.00465
Goyal, Uma D, et al. "Prospective Study of Use of Edmonton Symptom Assessment Scale Versus Routine Symptom Management During Weekly Radiation Treatment Visits." JCO oncology practice vol. 16,9 (2020): e1029-e1035. doi: https://doi.org/10.1200/JOP.19.00465
Goyal UD, Riegert K, Davuluri R, Ong S, Yi SK, Dougherty ST, Hsu CC. Prospective Study of Use of Edmonton Symptom Assessment Scale Versus Routine Symptom Management During Weekly Radiation Treatment Visits. JCO Oncol Pract. 2020 Sep;16(9):e1029-e1035. doi: 10.1200/JOP.19.00465. Epub 2020 May 08. PMID: 32384015.
Copy Download .nbib Format: NLM
Association between insurance variability and early lung function in children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Dickinson KM, Psoter KJ, Riekert KA, Collaco JM.
PMID: 34175244
J Cyst Fibros. 2021 Jun 23; doi: 10.1016/j.jcf.2021.06.006. Epub 2021 Jun 23.

BACKGROUND: Lower socioeconomic status (SES) has consistently been associated with poorer outcomes in individuals with cystic fibrosis (CF). Previous studies have compared outcomes for children with and without private insurance coverage, however the potential role of changes in insurance...

Cite
Dickinson KM, Psoter KJ, Riekert KA, et al. Association between insurance variability and early lung function in children with cystic fibrosis. J Cyst Fibros. 2021;doi: 10.1016/j.jcf.2021.06.006.
Dickinson, K. M., Psoter, K. J., Riekert, K. A., & Collaco, J. M. (2021). Association between insurance variability and early lung function in children with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, . https://doi.org/10.1016/j.jcf.2021.06.006
Dickinson, Kimberly M, et al. "Association between insurance variability and early lung function in children with cystic fibrosis." Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. (2021). doi: https://doi.org/10.1016/j.jcf.2021.06.006
Dickinson KM, Psoter KJ, Riekert KA, Collaco JM. Association between insurance variability and early lung function in children with cystic fibrosis. J Cyst Fibros. 2021 Jun 23; doi: 10.1016/j.jcf.2021.06.006. Epub 2021 Jun 23. PMID: 34175244.
Copy Download .nbib Format: NLM
Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents.

ACS medicinal chemistry letters

Singh SB, Kaelin DE, Wu J, Miesel L, Tan CM, Meinke PT, Olsen D, Lagrutta A, Bradley P, Lu J, Patel S, Rickert KW, Smith RF, Soisson S, Wei C, Fukuda H, Kishii R, Takei M, Fukuda Y.
PMID: 24900889
ACS Med Chem Lett. 2014 Mar 12;5(5):609-14. doi: 10.1021/ml500069w. eCollection 2014 May 08.

Bacterial resistance is eroding the clinical utility of existing antibiotics necessitating the discovery of new agents. Bacterial type II topoisomerase is a clinically validated, highly effective, and proven drug target. This target is amenable to inhibition by diverse classes...

Cite
Singh SB, Kaelin DE, Wu J, et al. Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents. ACS Med Chem Lett. 2014;5(5):609-14doi: 10.1021/ml500069w.
Singh, S. B., Kaelin, D. E., Wu, J., Miesel, L., Tan, C. M., Meinke, P. T., Olsen, D., Lagrutta, A., Bradley, P., Lu, J., Patel, S., Rickert, K. W., Smith, R. F., Soisson, S., Wei, C., Fukuda, H., Kishii, R., Takei, M., & Fukuda, Y. (2014). Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents. ACS medicinal chemistry letters, 5(5), 609-14. https://doi.org/10.1021/ml500069w
Singh, Sheo B, et al. "Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents." ACS medicinal chemistry letters vol. 5,5 (2014): 609-14. doi: https://doi.org/10.1021/ml500069w
Singh SB, Kaelin DE, Wu J, Miesel L, Tan CM, Meinke PT, Olsen D, Lagrutta A, Bradley P, Lu J, Patel S, Rickert KW, Smith RF, Soisson S, Wei C, Fukuda H, Kishii R, Takei M, Fukuda Y. Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents. ACS Med Chem Lett. 2014 Mar 12;5(5):609-14. doi: 10.1021/ml500069w. eCollection 2014 May 08. PMID: 24900889; PMCID: PMC4027601.
Copy Download .nbib Format: NLM
How to use nursing information sources.

Nursing outlook

Saba VK, Oatway DM, Rieder KA.
PMID: 2740260
Nurs Outlook. 1989 Jul-Aug;37(4):189-95.

No abstract available.

Cite
Saba VK, Oatway DM, Rieder KA. How to use nursing information sources. Nurs Outlook. 1989;37(4):189-95
Saba, V. K., Oatway, D. M., & Rieder, K. A. (1989). How to use nursing information sources. Nursing outlook, 37(4), 189-95.
Saba, V K, et al. "How to use nursing information sources." Nursing outlook vol. 37,4 (1989): 189-95.
Saba VK, Oatway DM, Rieder KA. How to use nursing information sources. Nurs Outlook. 1989 Jul-Aug;37(4):189-95. PMID: 2740260.
Copy Download .nbib Format: NLM
A Rutile Chevron Modulation in Delafossite-Like Ga3-xIn3TixO9+x/2.

Inorganic chemistry

Rickert K, Boullay P, Malo S, Caignaert V, Poeppelmeier KR.
PMID: 27089247
Inorg Chem. 2016 May 02;55(9):4403-9. doi: 10.1021/acs.inorgchem.6b00147. Epub 2016 Apr 18.

The structure solution of the modulated, delafossite-related, orthorhombic Ga3-xIn3TixO9+x/2 for x = 1.5 is reported here in conjunction with a model describing the modulation as a function of x for the entire system. Previously reported structures in the related...

Cite
Rickert K, Boullay P, Malo S, et al. A Rutile Chevron Modulation in Delafossite-Like Ga3-xIn3TixO9+x/2. Inorg Chem. 2016;55(9):4403-9doi: 10.1021/acs.inorgchem.6b00147.
Rickert, K., Boullay, P., Malo, S., Caignaert, V., & Poeppelmeier, K. R. (2016). A Rutile Chevron Modulation in Delafossite-Like Ga3-xIn3TixO9+x/2. Inorganic chemistry, 55(9), 4403-9. https://doi.org/10.1021/acs.inorgchem.6b00147
Rickert, Karl, et al. "A Rutile Chevron Modulation in Delafossite-Like Ga3-xIn3TixO9+x/2." Inorganic chemistry vol. 55,9 (2016): 4403-9. doi: https://doi.org/10.1021/acs.inorgchem.6b00147
Rickert K, Boullay P, Malo S, Caignaert V, Poeppelmeier KR. A Rutile Chevron Modulation in Delafossite-Like Ga3-xIn3TixO9+x/2. Inorg Chem. 2016 May 02;55(9):4403-9. doi: 10.1021/acs.inorgchem.6b00147. Epub 2016 Apr 18. PMID: 27089247.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 54 entries